Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1044-2023Class II

BIOPSY MEDIUM 10ML, Reference Number 10620010 A, used for blastomere biopsy of cleavage stage embryos for...

CooperSurgical, Inc. / initiated 2022-12-15 / Open, Classified / root cause: labeling and UDI

CooperSurgical, Inc. began a recall of BIOPSY MEDIUM 10ML, Reference Number 10620010 A, used for blastomere biopsy of cleavage stage embryos for Pre-implantation Genetic Diagnosis (PGD) on . FDA classified it as Class II and gives the reason as "The affected product may contain a medium other than the Biopsy Medium. There is a risk that use of the Product from this lot could cause degradation of the embryo". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1044-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
CooperSurgical, Inc.
Product
BIOPSY MEDIUM 10ML, Reference Number 10620010 A, used for blastomere biopsy of cleavage stage embryos for Pre-implantation Genetic Diagnosis (PGD)
Product code
MQL Media, Reproductive
Reason for recall
The affected product may contain a medium other than the Biopsy Medium. There is a risk that use of the Product from this lot could cause degradation of the embryo.
Root cause tag
labeling and UDI
FDA root cause
Labeling Change Control
Action
An "URGENT: VOLUNTARY MEDIA RECALL" letter dated 12/13/22 was sent to customers. Actions to be Taken: For both CUSTOMERS and DISTRIBUTORS: Inspect your stock for the Product from this lot. Lot information can be found on the box and bottle labeling. o If found, quarantine, and discontinue use of the Product from this lot immediately. o Return the Product to CooperSurgical through our Recall Return process. Credit will be applied to your account for reorder of correct product per our Recall process with no additional cost to you or your facilities. For CUSTOMERS: If you have the affected Product, contact CooperSurgical at [email protected]. Or call +1-203-601-5200 and follow the phone prompt to enter the ext. 3300. If you received this letter (even if you do not have the specific lot remaining in stock), please complete and return the enclosed Customer Acknowledgement Form to [email protected]. For DISTRIBUTORS: If the Product has been distributed to your customers, send this letter (including the Customer Acknowledgement Form) to your customers. Complete and return the enclosed Distributor Acknowledgement and Receipt Form to [email protected]. Please feel free to reach us at +1-203-601-5200 and follow the phone prompt to enter the ext. 3300 or via email at [email protected].
Quantity in commerce
489 units
Distribution
Global Distribution including countries of: Bahrain, Belgium, Bulgaria, Egypt, France, Georgia, Greece, Hong Kong, Iran, Iraq, Israel, Japan, Jordan, Kazakhstan, Kuwait, Lebanon, Libya, Nigeria, Oman, Pakistan, Poland, Republic of North Macedonia, Saudi Arabia, Slovenia, Spain, Thailand, Turkey, Turkmenistan, and United Arab Emirates.
Product codes and lots
Lot Number: 220506-006557

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1044-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1044-2023Class IIOngoingVoluntary: Firm initiated